miR-200c was upregulated in pancreatic cancer stem-like cells by garcinol targeting Notch1/Oct4 resulting in a loss of stemness [14] and miR-181 was upregulated in glioblastoma cells by inhibiting STAT3 resulting in reduced migration/invasion [15]. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.